Gene · 337
Papers3,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apolipoprotein A-IV and a rare case of scintigraphy-negative cardiac amyloidosis. | Eur Heart J Case Rep | 2025 | 40726612 | PubTator, text mining | PubMed |
| Gut Hormones and Inflammatory Bowel Disease. | Biomolecules | 2025 | 40723884 | PubTator, text mining | PubMed |
| Covalent Organic Frameworks for Immunoassays: A Review. | Biosensors (Basel) | 2025 | 40710118 | PubTator, text mining | PubMed |
| Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease. | J Appl Lab Med | 2025 | 40697012 | PubTator, text mining | PubMed |
| Subcutaneous adipose tissue-secreted proteins as endocrine regulators of physical and cognitive function in older adults. | Mol Metab | 2025 | 40675551 | PubTator, text mining | PubMed |
| Genome-wide study links cardiometabolic factors to cognition via APOA4-APOA5-ZPR1-BUD13 and other loci in rural Indians. | Alzheimers Dement | 2025 | 40665476 | PubTator, text mining | PubMed |
| Serum and Urinary Proteomic Signatures Revealing Redox and Metabolic Dysregulation in Acute Achilles Tendon Rupture. | Protein Pept Lett | 2025 | 40641011 | PubTator, text mining | PubMed |
| Gut microbiota and the "gut-liver-kidney axis" theory: from mechanisms to therapeutics. | Front Microbiol | 2025 | 40611955 | PubTator, text mining | PubMed |
| Hub biomarkers and their clinical relevance in glycometabolic disorders: A comprehensive bioinformatics and machine learning approach. | Chin Med J (Engl) | 2025 | 40539266 | PubTator, text mining | PubMed |
| Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C. | J Thromb Haemost | 2025 | 40499720 | PubTator, text mining | PubMed |
| Urinary apolipoprotein A4 as a biomarker for renal allograft injury in kidney transplant recipients. | PLoS One | 2025 | 40397923 | PubTator, text mining | PubMed |
| Potential of CETP inhibition in treating dyslipidemia in systemic lupus erythematosus: Novel and comprehensive evidence from clinical studies and Mendelian randomization. | Int Immunopharmacol | 2025 | 40315629 | PubTator, text mining | PubMed |
| Identification of unique biomarkers for proliferative diabetic retinopathy with tractional retinal detachment by proteomics profiling of vitreous humor. | Sci Rep | 2025 | 40251337 | PubTator, text mining | PubMed |
| Amyloid-forming property of the N-terminal 1-70 residues of human apolipoprotein A-IV. | Sci Rep | 2025 | 40240491 | PubTator, text mining | PubMed |
| Multi-omics analysis of copper metabolism-related molecular subtypes and risk stratification for osteosarcoma. | Discov Oncol | 2025 | 40192894 | PubTator, text mining | PubMed |
| An integrated proteomic classifier to distinguish benign from malignant pulmonary nodules. | Clin Proteomics | 2025 | 40189512 | PubTator, text mining | PubMed |
| Identification of Potential Functional Modules and Diagnostic Genes for Crohn's Disease Based on Weighted Gene Co-expression Network Analysis and LASSO Algorithm. | Turk J Gastroenterol | 2025 | 40181741 | PubTator, text mining | PubMed |
| Small Bowel Perforation in Roux-en-Y Gastric Bypass (RYGB) Secondary to Apolipoprotein A-IV (AApoA-IV) Type Amyloidosis. | Obes Surg | 2025 | 40156753 | PubTator, text mining | PubMed |
| PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes. | Diagnostics (Basel) | 2025 | 40150005 | PubTator, text mining | PubMed |
| Structural analyses of apolipoprotein A-IV polymorphisms Q360H and T347S elucidate the inhibitory effect against thrombosis. | J Biol Chem | 2025 | 40074081 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/337/papers?page=5